The Drug Eluting market Growth  of Drug Eluting Stents was estimated to be USD 2897.6 million in 2022. It is projected to reach USD 4795.51 million by 2030, with a compound annual growth rate (CAGR) of 6.5% during the forecast period from 2023 to 2030.

Drug Eluting Stents are a vital component of the medical industry, offering significant potential for growth and development. The market's estimated value in 2022, at USD 2897.6 million, showcases its current standing. However, this figure is expected to soar to USD 4795.51 million by 2030, indicating a promising future for this sector.

The projected CAGR of 6.5% during the forecast period from 2023 to 2030 further emphasizes the steady and sustainable growth trajectory of the Drug Eluting Stent market. This growth rate signifies the increasing demand and adoption of these stents, driven by advancements in medical technology and rising awareness among healthcare professionals and patients alike.

As the market expands, it presents numerous opportunities for stakeholders, including manufacturers, suppliers, and investors, to capitalize on this upward trend. The rising prevalence of cardiovascular diseases, coupled with the aging population and lifestyle changes, contributes to the growing demand for Drug Eluting Stents.

In conclusion, the Drug Eluting Stent market is poised for substantial growth, with an estimated value of USD 2897.6 million in 2022, projected to reach USD 4795.51 million by 2030. The anticipated CAGR of 6.5% during the forecast period highlights the market's potential and attractiveness for industry players.

Get Sample Report @ https://www.snsinsider.com/sample-request/3323

Market Segmentation Analysis

By Type

• Coronary Stenting
• Peripheral Stenting

By Scaffold

• Cobalt-Chromium
• Platinum-Chromium
• Nitinol
• Others

By Drug

• Sirolimus
• Paclitaxel
• Zotarolimus
• Everolimus
• Others

By End User

• Hospitals
• Specialty Clinics

Key Players 

The major key players are Abbott Laboratories, Boston Scientific Corporation, Medtronic, Cordis Corporation (a Johnson & Johnson company), Terumo Corporation, Biosensors International Group, Ltd, Biotronik SE & Co. KG, St. Jude Medical, Inc. and others.

Table of Contents

1.Introduction

2.Research Methodology

3.Market Dynamics

4.Impact Analysis

4.1COVID-19 Impact Analysis

4.2.Impact of Ukraine- Russia war

4.3.Impact of Ongoing Recession on Major Economies

5.Value Chain Analysis

6.Porter’s 5 Forces Model

7.PEST Analysis

8.Healthcare Asset Management  Market Segmentation, By  Biomarkers Type

9.Healthcare Asset Management  Market Segmentation, By Cancer Type

10.Cancer biomarkers market, By Profiling Technologies

11.Company Profiles

12 Competitive Landscape

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us:

Akash Anand – Head of Business Development & Strategy

info@snsinsider.com

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

Website: https://www.snsinsider.com